PMC:7116472 / 511-826 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"18","span":{"begin":79,"end":90},"obj":"Species"},{"id":"19","span":{"begin":237,"end":245},"obj":"Species"}],"attributes":[{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Tax:11118"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Clinical Characterisation Protocol UK (CCP-UK) study (performed by the ISARIC Coronavirus Clinical Characterisation Consortium—ISARIC-4C) in 260 hospitals across England, Scotland, and Wales. Model training was performed on a cohort of patients recruited between 6 February and 20 May 2020, with validation conduct"}